The market expects Tarsus Pharmaceuticals, Inc. (TARS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This ...

Tarsus Pharmaceuticals (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend ...

Tarsus Pharmaceuticals (NASDAQ:TARS) has pared some of an earlier gain of as much as 13% and is now up 8%  amid a report that ...

On Friday, Tarsus Pharmaceuticals Inc (TARS) stock saw a modest uptick, ending the day at $39.41 which represents a slight increase of $0.52 or 1.34% from the prior close of $38.89. The stock opened ...

Harbor Capital Advisors Inc. raised its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 57.5% in the third quarter, according to the company in its most recent filing ...

On Tuesday, Tarsus Pharmaceuticals Inc (TARS) stock saw a modest uptick, ending the day at $43.87 which represents a slight increase of $4.20 or 10.59% from the prior close of $39.67. The stock opened ...

Tarsus Pharmaceuticals (TARS) announced the appointment of Elizabeth Yeu, M.D., as Chief Medical Officer, effective November 4, 2024. Dr. Yeu ...

The latest announcement is out from Tarsus Pharmaceuticals ( (TARS) ). Tarsus Pharmaceuticals appointed Elizabeth Yeu, M.D. as Chief Medical ...

View Tarsus Pharmaceuticals, Inc. (TARS) current and estimated P/E ratio data provided by Seeking Alpha.

Tarsus Pharmaceuticals, Inc. (TARS) shares ended the last trading session 10.6% higher at $43.87. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.